Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP Announces Webcast and Conference Call of First Quarter 2010 Results
LYON, France, May 3, 2010 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its first quarter 2010 results announcement, which will take place on Tuesday, May 18, 2010, before the opening of the
View HTML
Toggle Summary EDAP Outlines U.S. ENLIGHT Clinical Strategy
Ablatherm HIFU Trial Update: IDE Submission Expected in 2012
View HTML
Toggle Summary EDAP Highlights Ablatherm-HIFU and Sonolith i-move at European Association of Urology Conference
Launches Sonolith i-move Lithotripsy Device Ablatherm-HIFU Featured as Superior Technology
View HTML
Toggle Summary EDAP Receives European Approval for New Sonolith i-move Lithotripsy Device
Official Marketing Launch at European Association Urology Congress, Barcelona
View HTML
Toggle Summary EDAP Reports Record Full Year 2009 Financial Results
2009 Full Year Highlights: , Mar 30, 2010 (GlobeNewswire via COMTEX News Network) -- Record revenue for the third consecutive year: EUR 24.9 million (USD 34.7 million), up 7.9% -- Gross margin increased to a five year high 43.0% compared to prior year 39.8% -- Strong cash position of EUR 12.7
View HTML
Toggle Summary EDAP Ablatherm(R)-HIFU Nominated for European Inventor Award 2010
LYON, France, Mar 22, 2010 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, reported today that the INSERM team and Emmanuel Blanc, the Company's Chief Technology Officer, have been nominated for the European Inventor Award 2010.
View HTML
Toggle Summary EDAP Announces Webcast and Conference Call of Fourth Quarter and Full Year 2009 Results
LYON, France, Mar 10, 2010 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its fourth quarter and full year 2009 results announcement, which will take place on Tuesday, March 30, 2010, before the
View HTML
Toggle Summary EDAP Receives Japanese Approval for Sonolith I-Sys
Enters Largest Global Lithotripsy Market
View HTML
Toggle Summary EDAP Presents Ablatherm-HIFU Data in Localized Prostate Cancer at Third Focal Therapy Symposium
Session Emphasizes Attractiveness of Ablatherm-HIFU in Focal Therapy
View HTML
Toggle Summary EDAP Reports Record Full Year 2009 Preliminary Unaudited Results
2009 Highlights: , Feb 16, 2010 (GlobeNewswire via COMTEX News Network) -- Record revenue of EUR 24.9 million (USD 34.7 million), up 7.9% year-over-year -- Ablatherm-HIFU RPP treatments increased 24.0% year-over-year -- Strong EUR 12.7 million (USD 18.2 million) cash position LYON, France, Feb.
View HTML